Detailed information for compound 1359168

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 324.438 | Formula: C16H24N2O3S
  • H donors: 1 H acceptors: 3 LogP: 2.06 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(N1CCCCCCC1)CCNS(=O)(=O)c1ccccc1
  • InChi: 1S/C16H24N2O3S/c19-16(18-13-7-2-1-3-8-14-18)11-12-17-22(20,21)15-9-5-4-6-10-15/h4-6,9-10,17H,1-3,7-8,11-14H2
  • InChiKey: GQLJXWWSYKIHLO-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens ATPase family, AAA domain containing 5 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis atpase aaa+ type core atpase aaa type core Get druggable targets OG5_139225 All targets in OG5_139225
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma cruzi DNA repair and recombination helicase protein PIF6, putative 0.1322 1 1
Brugia malayi MAP kinase sur-1 0.005 0 0.5
Entamoeba histolytica DNA repair and recombination protein, putative 0.1322 1 0.5
Trypanosoma brucei DNA repair and recombination helicase protein PIF6 0.1322 1 1
Trypanosoma brucei DNA repair and recombination helicase protein PIF7 0.1322 1 1
Leishmania major PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative 0.1322 1 1
Trypanosoma cruzi DNA repair and recombination helicase protein PIF7, putative 0.1322 1 1
Leishmania major PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative 0.1322 1 1
Schistosoma mansoni hypothetical protein 0.1322 1 1
Entamoeba histolytica hypothetical protein, conserved 0.1322 1 0.5
Giardia lamblia Rrm3p helicase 0.1322 1 1
Echinococcus multilocularis ATP dependent DNA helicase PIF1 0.1322 1 1
Echinococcus multilocularis atpase aaa+ type core atpase aaa type core 0.0979 0.7306 0.7306
Trypanosoma cruzi DNA repair and recombination helicase protein PIF7, putative 0.1322 1 1
Loa Loa (eye worm) CMGC/MAPK/ERK1 protein kinase 0.005 0 0.5
Trichomonas vaginalis conserved hypothetical protein 0.1322 1 1
Toxoplasma gondii CMGC kinase, MAPK family (ERK) MAPK-1 0.005 0 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 9.1962 uM PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] ChEMBL. No reference
Potency (functional) 23.0999 uM PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.